Volume 64 - Number 3
ARTICLES
Prescriptions for Compliance with the Foreign Corrupt Practices Act: Identifying Bribery Risks and Implementing Anti-Bribery Controls in Pharmaceutical and Life Sciences Companies
64(3): 691 - 737 (May 2009)
Litigating in LLCs
64(3): 739 - 755 (May 2009)
Liquidated Damages in Commercial Leases of Personalty -- The Proper Analysis
64(3): 757 - 781 (May 2009)
The Role of Lead Counsel in Syndicated Lending Transactions
64(3): 783 - 800 (May 2009)
SURVEY
Annual Review of Federal Securities Regulation
64(3): 833 - 835 (May 2009)
Significant 2008 Accounting Developments
64(3): 837 - 847 (May 2009)
Significant 2008 Regulatory Developments
64(3): 849 - 870 (May 2009)
Significant 2008 Caselaw Developments
64(3): 871 - 971 (May 2009)
Survey - Federal Regulation of Securities - May 2009
64(3): 833 - 971 May 2009)
Annual Review of Federal Securities Regulation for May 2008
